Cardica, Inc.  

(Public, NASDAQ:CRDC)   Watch this stock  
Find more results for crdc
0.690
+0.005 (0.69%)
Dec 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.68 - 0.71
52 week 0.56 - 1.61
Open 0.70
Vol / Avg. 44,025.00/650,189.00
Mkt cap 61.38M
P/E     -
Div/yield     -
EPS -0.31
Shares 88.96M
Beta 1.42
Inst. own 54%
Feb 2, 2015
Q2 2015 Cardica Inc Earnings Release (Estimated) Add to calendar
Nov 4, 2014
Q1 2015 Cardica Inc Earnings Call - Webcast
Nov 4, 2014
Q1 2015 Cardica Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin -474.25% -469.32%
Operating margin -464.33% -456.46%
EBITD margin - -418.09%
Return on average assets -44.96% -51.93%
Return on average equity -98.71% -111.24%
Employees 75 -
CDP Score - -

Address

900 Saginaw Drive
REDWOOD CITY, CA 94063
United States - Map
+1-650-3649975 (Phone)
+1-650-3643134 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Cardica, Inc. (Cardica) is focused on the development of an endoscopic microcutter product line intended for use by thoracic, bariatric, colorectal and general surgeons. The first product that it is developing in its microcutter product line is the Microcutter XPRESS 30, the multi-fire endolinear microcutter device based on its staple-on-a-strip technology. In addition, the Company is developing the Microcutter XPRESS 45, a multi-fire endolinear microcutter device with a 45 millimeter staple line, the Microcutter XCHANGE 30, a cartridge based microcutter device with a 5 millimeter shaft diameter and a 30 millimeter staple line, the Microcutter FLEXCHANGE 30, a cartridge based microcutter device with a flexible shaft to facilitate endoscopic procedures requiring cutting and stapling, and the Microcutter XPRESS 60, a cutting and stapling device specifically designed for the bariatric and thoracic surgery markets.

Officers and directors

Kevin T. Larkin Independent Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Bernard A. Hausen M.D.,Ph.D. President, Chief Executive Officer, Chief Medical Officer, Director
Age: 53
Bio & Compensation  - Reuters
Robert Y. Newell IV Chief Financial Officer, Vice President - Finance
Age: 65
Bio & Compensation  - Reuters
Frederick M. Bauer Vice President - Operations
Age: 59
Bio & Compensation  - Reuters
Liam J Burns Vice President - Sales and Marketing
Bio & Compensation  - Reuters
Bryan D. Knodel Ph.D. Vice President - Research & Development
Age: 53
Bio & Compensation  - Reuters
William P. Moffitt III Independent Director
Bio & Compensation  - Reuters
Gary S. Petersmeyer Independent Director
Age: 67
Bio & Compensation  - Reuters
Richard P. Powers Independent Director
Age: 69
Bio & Compensation  - Reuters
Jeffrey L. Purvin Independent Director
Age: 61
Bio & Compensation  - Reuters